LLY

1,063.79

-1.23%↓

JNJ

222.81

-0.32%↓

ABBV

215.58

+1.54%↑

UNH

377.18

-0.59%↓

MRK

115.96

+0.86%↑

LLY

1,063.79

-1.23%↓

JNJ

222.81

-0.32%↓

ABBV

215.58

+1.54%↑

UNH

377.18

-0.59%↓

MRK

115.96

+0.86%↑

LLY

1,063.79

-1.23%↓

JNJ

222.81

-0.32%↓

ABBV

215.58

+1.54%↑

UNH

377.18

-0.59%↓

MRK

115.96

+0.86%↑

LLY

1,063.79

-1.23%↓

JNJ

222.81

-0.32%↓

ABBV

215.58

+1.54%↑

UNH

377.18

-0.59%↓

MRK

115.96

+0.86%↑

LLY

1,063.79

-1.23%↓

JNJ

222.81

-0.32%↓

ABBV

215.58

+1.54%↑

UNH

377.18

-0.59%↓

MRK

115.96

+0.86%↑

Home・Stock List・Medpace Holdings Inc

Medpace Holdings Inc

Closed

SectorHealthcare

445.43 -1.07

Buy Sell

Overview

Share price change

24h

Current

Min

436.53

Max

449.42

Key metrics
By Trading Economics
Income	-11M 124M
Sales	-1.8M 707M
P/E Sector Avg	26.908 50.102
EPS	4.28
Profit margin	17.53
Employees	6,300
EBITDA	-16M 148M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	-0.88% downside

Dividends
By Dow Jones
Next Earnings	20 Jul 2026

Market Stats
By TradingEconomics
Market Cap	-2.9B 12B
Previous open	446.5
Previous close	445.43

News Sentiment

By Acuity

92%

323 / 344 Healthcare

Medpace Holdings Inc Chart

Past performance is not a reliable indicator of future results.

Related News

23 Oct 2025, 15:15 UTC

Earnings

Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back -- Barrons.com

Peer Comparison

Price change

Medpace Holdings Inc Forecast

Price Target

By TipRanks

-0.88% downside

12 Months Forecast

Average 447.5 USD -0.88%

High 495 USD

Low 393 USD

Based on 8 Wall Street analysts offering 12 month price targets forMedpace Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

Buy

Hold

Sell

Based on 8 analysts giving stock ratings to Medpace Holdings Inc - Dist in the past 3 months.

Sentiment

By Acuity

323 / 344 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.